Akero Therapeutics Inc buy BiotechBee
Start price
03.03.24
/
60%
€25.60
Target price
31.05.26
€35.00
Performance (%)
-23.77%
Price
22.04.24
€19.52
Summary
This prediction is currently active. The prediction for Akero Therapeutics Inc disappoints with a performance of -23.77%. This prediction currently runs until 31.05.26. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Akero Therapeutics Inc | -4.197% | -4.197% |
iShares Core DAX® | 2.594% | -1.158% |
iShares Nasdaq 100 | 3.553% | -1.727% |
iShares Nikkei 225® | 0.687% | -8.354% |
iShares S&P 500 | 2.209% | -0.942% |
According to BiotechBee what are the pros and cons of Akero Therapeutics Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Akero Therapeutics Inc diskutieren
Buy mit Kursziel 35,0
Stopped prediction by BiotechBee for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€47.80
01.10.23
01.10.23
€65.00
30.06.26
30.06.26
-71.13%
13.10.23
13.10.23
Could be very worthwhile Investment >20% year
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€38.20
04.11.22
04.11.22
€32.00
31.12.24
31.12.24
6.81%
21.12.22
21.12.22
Could be very worthwhile Investment >20% year
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€42.60
01.11.22
01.11.22
€55.00
31.12.24
31.12.24
-10.33%
04.11.22
04.11.22
Could be very worthwhile Investment >20% year
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€27.00
25.09.22
25.09.22
€16.00
31.12.24
31.12.24
57.78%
01.11.22
01.11.22
Could be very worthwhile Investment >20% year